Advanced Solid Tumor Clinical Trials in Xuzhou
2 recruitingXuzhou, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Advanced Solid TumorRefractory Hodgkin Lymphoma
FBD Biologics Limited50 enrolled6 locationsNCT06487624
Recruiting
Phase 2
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
AstraZeneca175 enrolled31 locationsNCT06271837